Perfluorinated compounds (PFCs) have been employed as surface treatment agents in a variety of products. Perfluorooctanoic acid (PFOA), a PFC that is globally found in the environment and in human tissues, has been increasing significantly in serum level over the past 50 years. Here, we demonstrate that PFOA inhibits feeding behavior as potently as an endogenous peroxisome proliferator-activated receptor (PPAR)-alpha ligand, oleoylethanolamide (OEA), via the activation of PPAR-alpha, the vagal nerve and hypothalamic neuropeptides. Peripherally-administered PFOA decreased food intake as potently as OEA. PFOA decreased gastric emptying and increased the expression level of the gene encoding urocortin 1 in the hypothalamus and the immunoreaction for urocortin 1 in the paraventricular nucleus. Vagotomy attenuated the inhibitory effects of PFOA on feeding. The inhibition of food intake and body weight gain by PFOA was completely mitigated in PPAR-alpha -/mice. Our studies demonstrate that the ubiquitous environmental pollutant PFOA works as a mimickry of OEA mimicking the action of OEA in the feeding regulatory system, providing a new mode of action as represented by environmental "anorexigens".
Introduction
Perfluorinated compounds (PFCs) have been industrially manufactured for over 50 years. Perfluorooctanoic acid (PFOA) is one of the most commonly occurring PFCs in the environment and human tissues (1, 2) . PFOA is resistant to degradation in soil, oil and water; hence, it has been employed as a surface-treatment agent in a variety of products such as metal plating and cleaning, coating formulations, fire-fighting foams, polyurethane production, inks, varnishes, vinyl polymerization, lubricants, and gasoline, and water repellents for leather, paper, and textiles (1, 2) . PFOA is a compound in which all carbon-hydrogen (C-H) bonds are replaced by carbon-fluorine (C-F) bonds (1, 2) . The C-F bond is one of the strongest bonds in nature and confers physical, thermal and chemical stabilities to most PFCs. Due to its broad application and environmental stability, PFOA is globally distributed and is bioaccumulative (3, 4) .
Several studies have reported the recent trend of accumulation of PFOA in individuals and pooled human serum samples from various countries (5, 6) . Olsen et al. reported that 3M employees involved in PFOA production had up to 6.16 mg/L PFOA in their blood; in the US, the level of PFOA in the general population varies from less than 1.9 µg/L to 52.3 µg/L and that in children varies from less than 1.9 µg/L to 56.1 µg/L (7, 8) . PFCs are readily absorbed but poorly eliminated. The half-life of PFOA in humans is estimated to be 3.8 years (9) . PFC levels in human serum have been shown to have increased significantly in recent years (6, 10) .
Animal toxicological studies have revealed that these chemicals have a potent anorexigenic effect in rodents and monkeys (11, 12) , but the mechanism underlying this effect has been unknown. As predicted by the structure similarity of PFOA to free fatty acids and their derivative oleoylethanolamide (OEA), its high affinity to peroxisome proliferator-activated receptor-alpha (PPAR-alpha) was confirmed (13, 14) . A reasonable conjecture based on its high affinity to PPAR-alpha predicts that an anorexic effect of PFOA is mediated by PPAR-alpha as that of OEA is (15) . In the present study, we tested this hypothesis.
Results
To investigate whether or not PFOA influences feeding behavior, we first examined the effects of intraperitoneal injection (ip) of PFOA on feeding in food-deprived mice. PFOA produced inhibitory effects on feeding behavior in a dose-dependent manner (Fig. 1A ).
Next, we compared the inhibitory effects of PFOA and OEA at the same molar concentration (100 µmol/kg) on feeding in the dark-phase. By 4 h after administration, PFOA decreased the level of feeding as potently as OEA did (Fig. 1B ). We also examined whether or not PFOA influenced the gastric emptying rate. In this study, PFOA administered ip significantly delayed gastric emptying 2 h after administration (Fig. 1C ).
In order to evaluate the possible action of PFOA through the hypothalamic pathway, we examined the effects of PFOA administered ip on the expression of genes encoding hypothalamic neuropeptides. Real-time reverse transcription polymerase chain reaction (real-time RT-PCR) analysis revealed an increase in the level of urocortin 1 expression by 51.2% compared with controls ( Fig. 2A ) after ip PFOS administration. We then tested whether or not PFOA increased the level of urocortin 1 in the PVN. As expected, immunohistochemical studies for urocortin 1 showed that, compared with controls, PFOA increased the immunoreactivity for urocortin 1 in the paraventricular nucleus (PVN) ( Fig.  2B ).
Using mice that underwent truncal vagotomy, we investigated whether the inhibitory effect of PFOA on feeding is associated with a vagally-mediated pathway. As shown in Fig.   3A , vagotomy attenuated the inhibitory effects of ip PFOA administration on feeding.
Moreover, exogenous PFOA increased the level of c-fos expression (40. 9 5.33 vs. 20.5
1.97 number/section [control], n = 4, P < 0.02) in the nucleus of the solitary tract (NTS) ( Fig. 3B ).
We also examined whether or not ip-administered PFOA inhibits food intake in PPAR-alpha -/mice. While food intake ( 
Discussion
We demonstrated that peripherally administered PFOA inhibitedfeeding behavior. It has been reported that OEA, an anorexigenic lipid mediator (15, 16) , is produced in a variety of tissues, including the small intestine, where the endogenous levels decrease during fasting and increase upon re-feeding (15) (16) (17) . OEA, administered ip or by an oral route, decreases the level of food intake in mice and rats (15) (16) (17) . Prior to the onset of the dark phase, OEA also decreases the level of food intake in non-food-deprived mice (15) . In our study, PFOA administered ip decreased food intake in the dark-phase as potently as OEA did. It has been shown that compounds that cause anorexia and cachexia delay gastric emptying as OEA inhibits the intestinal motility in mice (18) (19) (20) . As expected, exogenous PFOA significantly decreased gastric emptying rate.
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The discovery of leptin and ghrelin has enabled the mechanisms underlying the regulation of food intake at the molecular level (21, 22) . Thus far, hypothalamic neuropeptides, including neuropeptide Y (NPY), agouti-related protein (AGRP), orexin, melanin-concentrating hormone (MCH), proopiomelanocortin (POMC), cocaine and amphetamine-regulated transcript (CART), corticotropin-releasing factor (CRF), and urocortin, have been shown to be involved in the regulation of food intake (23) . We found that the level of urocortin 1 expression was increased after ip PFOA administration.
Urocortin 1 was the second ligand for the CRF receptor to be identified (24) . Whereas CRF is mainly involved in the regulation of stress-related behavior and colonic motility, urocortin 1 is mainly involved in the regulation of feeding behavior and gastric motility (25) . Previous studies have shown that urocortin 1 potently suppresses food intake and gastric emptying (25) . Additionally, Fonseca et al. have reported that ip-administered OEA increases the level of c-fos expression in the PVN, which is the primary site for the coordination of central anorexigenic signals (16) . In our study, PFOA increased the immunoreactivity for urocortin 1 in the PVN. Taken together, these results indicate that the anorexigenic activity of PFOA may be mediated, at least in part, via the activation of urocortin 1 in the PVN.
Previous studies have shown that peripheral satiety signals, including cholecystokinin, peptide YY, and pancreatic polypeptide, produce inhibitory effects on food intake via the activation of peripheral sensory fibers (19) . Peripherally-administered OEA fails to decrease food intake when those fibers have been removed either by truncal vagotomy or treatment with capsaicin (16) . We found that vagotomy attenuated the inhibitory effects of PFOA administration on feeding suggesting a vagus pathway that transfers anorexigenic signals induced by PFOA to the PVN. Moreover, PFOA increased the level of c-fos expression in the NTS, which processes vagal sensory inputs to the central nervous system. The increased c-fos expression in the NTS also supports the vagal transfer of the anorexigenic signals elicited by PFOA as seen with OEA (16) .
PPARs belong to the superfamily of nuclear hormone receptors that are ligand-activated transcription factors and play a crucial role in the metabolism of lipids and carbohydrates (26) . It has been suggested that PPAR-alpha has evolved to function as a key modulator of fatty acid catabolism during cellular fasting (26, 27) . Now, it has been recognized as a predominant target for the fibrate class of antihyperlipidemic drugs, including bezafibrate and clofibrate (26) . In addition, previous studies have shown that PPAR-alpha exhibits a high affinity for both PFOA and OEA (13, 14) . Several transactivation assays, reporter systems, and studies using different cell types have shown that human, mouse and rat PPAR-alpha are activated by PFOA (13, 14) . Moreover, PFOA activation is suppressed by PPAR-alpha antagonists (14) . These data indirectly suggest that the anorexigenic effect of PFOA is mediated by PPAR-alpha. Thus, we tested the involvement of PFOA using PPAR-alpha -/mice. While oral PFOA administration decreased food intake and body weight in wild mice, neither food intake nor body weight decreased in PPAR-alpha -/mice. These observations indicate that PFOA elicits an anorexigenic effect through the binding of PPAR-alpha.
Our studies indicate that the ubiquitous environmental pollutant PFOA potently inhibits feeding behavior. This effect is mediated by PPAR-alpha, transferred by the vagal nerve, and is accompanied by increased expression of the anorexic peptide urocortin 1 and delays in gastric emptying. The global historical industry-wide production of total PFOA for the period 1951-2004 is estimated to be 3600-5700 tons (28) . The present study clearly demonstrates that PFOA may mimic the endogenous PPAR-alpha ligand, OEA (26, 29) .
The present evidence, in turn, raises concern about the pharmacological action of PFOA in humans, since its effects might include various behavioral changes, not only in food intake but also other reproductive and motor activities similar to OEA (30) . We believe that further efforts are required to monitor the level of PFOA currently found ubiquitously worldwide.
Methods

Animals and chemicals
The study protocol was approved by the Animal Research Ethics Committee of Kyoto PFOA was diluted in distilled water and administered in a 10 ml/kg volume.
Feeding tests
Before feeding tests, mice were deprived of food for 16 hours with free access to water, or were given free access to food and water. A standard diet (F-2, 3.73 kcal/g, Funahashi Farm Corp., Chiba, Japan) was used except in the experiment testing the effect of vagotomy on feeding suppression induced by PFOA, which used a liquid diet (Oriental Yeast Co. Ltd., Tokyo, Japan). In experiments with food-deprived mice, drugs were administered at 10:00 a.m. In dark-phase feeding studies with non-food-deprived mice, drug administrations were performed immediately before lights-off (9:00 p.m.). The drug was dissolved in physiologic saline containing 1% DMSO to a final volume of 100 µl for ip administration. Food intake was measured by subtracting uneaten food from initially premeasured food at 20 min, 1 h, 2 h, 4 h, 12 h and 24 h after administration, and checking the food spillage.
Gastric emptying
Before the experiments for gastric emptying, mice were deprived of food for 16 h with free access to water. The fasted mice had free access to pre-weighed pellets for 1 hour; they were then ip administered PFOA (30-100 µmol/kg) or vehicle. The mice were deprived of food again for 2 h after drug administration. Food intake was measured by weighing the uneaten pellets. Mice were sacrificed by cervical dislocation 3 h after the start of experiments. Immediately after sacrifice, the stomach was exposed by laparotomy, quickly ligated at both the pylorus and cardia, then removed; at this point the dry content was weighed. Contents were dried using a vacuum freeze 
Immunohistochemistry
Mice were deprived of food for 16 h with free access to water. They were then subjected to ip administration of PFOA (100 µmol/kg) or vehicle. The mice were anesthetized with sodium pentobarbital (80-85 mg/kg ip) and perfused with 4% paraformaldehyde, 0.5% glutaraldehyde and 0.2% picric acid in 0.1 M phosphate buffer 90 min after administration.
The brains were removed and postfixed with 4% paraformaldehyde and 0.2% picric acid in 0.1 M phosphate buffer. The brains were cut into 20 µm-thick coronal sections using a cryostat. Sections cut through the NTS of PFOA-or vehicle-administered mice were prepared for immunohistochemistry using a c-fos antibody (rabbit polyclonal, Oncogene
Research Products, CA, USA) with ABC and DAB methods. Sections cut through the PVN were prepared for immunofluorescence staining for urocortin 1. Brain sections were incubated with a urocortin 1 antibody (rabbit polyclonal, Yanaihara Institute Inc., Shizuoka, Japan) and then incubated with Cy3-labeled anti-rabbit IgG (Chemicon International Inc.).
Immunoreactivity was observed under a light microscopy (Olympus DX51; Olympus
Optical Co. Ltd., Tokyo, Japan) or using a laser scanning microscope (LSM 510; Carl Zeiss Inc. Japan, Tokyo, Japan).
Truncal Vagotomy
Four days before experiments, truncal vagotomy was performed as follows. The mice were anesthetized with sodium pentobarbital (80-85 mg/kg ip). After making a midline incision of the abdominal wall, the stomach was covered with sterile gauze moistened with warm saline. The lower part of the esophagus was exposed and the anterior and posterior branches of the vagal nerve were incised. At the end of the operation, the abdominal wall was sutured in two layers. In sham-operated mice, vagal trunks were similarly exposed, but not cut. Vagotomized and sham-operated mice were maintained on a nutritionally-complete liquid diet. Completeness of vagotomy was verified during postmortem inspection. Mice were fixed for enzyme histochemistry and loss of acetylcholineesterase-positive fibers in the gastrointestinal tracts was determined by light microscopic observation.
Repeated Administrations
Repeated oral administrations of PFOA (50 µmol/kg/day) were continued for 6 days in PPAR-alpha -/and wild-type 129S1/SvImJ mice. The mice were administered PFOA daily at 8:00 PM. Food intake and body weight were measured daily.
Statistical analysis
The differences between means were assessed by ANOVA followed by Scheffe's method or the Student's t test when appropriate. Results are expressed as the mean values SE. P < 0.05 compared with the control group was considered to be statistically 13 significant. 
Figure legends
